TRANCE, a tumor necrosis factor family member critical for CD40 ligand- independent T helper cell activation

Journal of Experimental Medicine

Volumn 189, Issue 7, 1999, Pages 1025-1031

  Bachmann, Martin F ^a   Wong, Brian R ^c   Josien, Régis ^c   Steinman, Ralph M ^c   Oxenius, Annette ^b   Choi, Yongwon ^c  

^a BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

^b INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

CD40 ligand; Dendritic cell; T cell; TRANCE; Virus

Indexed keywords

CD40 ANTIGEN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; DENDRITIC CELL; HELPER CELL; IMMUNE RESPONSE; LIGAND BINDING; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; T LYMPHOCYTE ACTIVATION; VIRUS CELL INTERACTION; VIRUS INFECTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD40; CARRIER PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DENDRITIC CELLS; GERMINAL CENTER; IMMUNITY, CELLULAR; IMMUNOGLOBULIN ISOTYPES; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOKINES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, TUMOR NECROSIS FACTOR; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033526021     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.7.1025     Document Type: Article

References (29)

1. Foy, T.M., A. Aruffo, J. Bajorah, J.E. Buhlmann, and R.J. Noelle. 1996. Immune regulation by CD40 and its ligand. Annu. Rev. Immunol. 14:591-617.
2. Grewal, I.S., and R.A. Flavell. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16:111-136.
3. Van Kooten, C., and J. Banchereau. 1996. CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv. Immunol. 61:1-77.
4. Grewal, I.S., J. Xu, and R.A. Flavell. 1995. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature. 378:617-620.
5. van Essen, D., H. Kikutani, and D. Gray. 1995. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature. 378:620-623.
6. Campbell, K.A., P.J. Ovendale, M.K. Kennedy, W.C. Fanslow, S.G. Reed, and C.R. Maliszewski. 1996. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity. 4:283-289.
7. Kamanaka, M., P. Yu, T. Yasui, K. Yoshida, T. Kawabe, T. Horii, T. Kishimoto, and H. Kikutani. 1996. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity. 4:275-281.
8. Soong, L., J.-C. Xu, I.S. Grewal, P. Kima, J. Sun, B.J. Longley, Jr., N.H. Ruddle, D. McMahon-Pratt, and R.A. Flavell. 1996. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity. 4:263-273.
9. Cella, M., F. Sallusto, and A. Lanzavecchia. 1997. Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9:10-16.
10. Banchereau, J., and R.M. Steinman. 1998. Dendritic cells and the control of immunity. Nature. 392:245-252.
11. + T cells. J. Immunol. 154:5071-5079.
12. Koch, F., U. Stanzl, P. Jennewein, K. Janke, C. Heufler, E. Kämpgen, N. Romani, and G. Schuler. 1996. High level IL-12 production by rnurine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10 J. Exp. Med. 184:741-746.
13. Cella, M., D. Scheider, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:747-752.
14. Grewal, I.S., H.G. Foellmer, K.D. Grewal, J. Xu, F. Hardardottir, J.L. Baron, C.A. Janeway, Jr., and R.A. Flavell. 1996. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science. 273:1864-1867.
15. Larsen, C.P., E.T. Elwood, D.Z. Alexander, S.C. Ritchie, R. Hendrix, B.C. Tucker, H.R. Cho, A. Aruffo, D. Hollenbaugh, P.S. Linsley, et al. 1996. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature. 381:434-438.
16. + T-helper and a T-killer cell. Nature. 393:474-478.
17. Bennett, S.R., F.R. Carbone, F. Karamalis, R.A. Flavell, J.F. Miller, and W.R. Heath. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature. 393:478-480.
18. Schoenberger, S.P., R.E. Toes, E.I. van der Voort, R. Offringa, and C.J. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature. 393:480-483.
19. + T cell functions. J. Exp. Med. 183:2209-2218.
20. + CTL response. J. Exp. Med. 183:2129-2142.
21. Whitmire, J.K., M.K. Slifka, I.S. Grewal, R.A. Flavell, and R. Ahmed. 1996. CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection. J. Virol. 70: 8375-8381.
22. Notarangelo, L.D., M. Duse, and A.G. Ugazio. 1992. Immunodeficiency with hyper-IgM (HIM). Immunodefic. Rev. 3:101-121.
23. Wong, B.R., J. Rho, J. Arron, E. Robinson, J. Orlinick, M. Chao, S. Kalachikov, E. Cayani, F.S. Bartlett III, W.N. Frankel, S.Y. Lee, and Y. Choi. 1997. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinases in T cells. J. Biol. Chem. 272: 25910-25914.
24. Wong, B.R., R. Josien, S.Y. Lee, B. Sauter, H.-L. Li, R.M. Steinman, and Y. Choi. 1997. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 186:2075-2080.
25. Anderson, D.M., E. Maraskovsky, W.L. Billingsley, W.C. Dougall, M.E. Tometsko, E.R. Roux, M.C. Teepe, R.F. DuBose, D. Cosman, and L. Galibert. 1997. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature. 390:175-179.
26. Kawabe, T., T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara, N. Suematsu, N. Yoshida, T. Kishimoto, and H. Kikutani. 1994. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity. 1:167-178.
27. Wysocka, M., M. Kubin, L.Q. Vieira, L. Ozmen, G. Garotta, P. Scott, and G. Trinchieri. 1995. Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 25:672-676.
28. Bachmann, M.F., B. Odermatt, H. Hengartner, and R.M. Zinkernagel. 1996. Induction of long-lived germinal centers associated with persisting antigen after viral infection. J. Exp. Med. 183:2259-2269.
29. Mach, F., U. Schonbeck, G.K. Sukhova, E. Atkinson, and P. Libby. 1998. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature. 394:200-203.